Organ preservation for adenoid cystic carcinoma of the larynx

Keyphrases

• Adenoid Cystic Carcinoma 100%
• Adjuvant Radiotherapy 20%
• Cancer Institute 20%
• Carboplatin 40%
• Chemoradiotherapy 60%
• Combined Chemoradiotherapy 20%
• Definitive Chemoradiation 20%
• Dermatitis 20%
• Desquamative 20%
• Disease-free 20%
• Laryngectomy 40%
• Local-regional Control 40%
• Locally Advanced 20%
• Locally Recurrent 20%
• Mucositis 20%
• Nave 20%
• Organ Preservation 100%
• Organ Sparing 20%
• Paclitaxel 40%
• Patient Selection 20%
• Patient-completed 20%
• Potential Alternatives 20%
• Primary Chemoradiotherapy 20%
• Pulmonary Metastasis 20%
• Radiotherapy 40%
• Rare Diseases 20%
• Severe Dysphagia 20%
• Total Dose 20%
• Treatment Breaks 20%
• Treatment Delay 20%
• Treatment Modalities 20%

Medicine and Dentistry

• Adjuvant Radiotherapy 16%
• Carboplatin 33%
• Chemoradiotherapy 100%
• Cylindroma 100%
• Dermatitis 16%
• Disease 16%
• Laryngectomy 33%
• Larynx 100%
• Lung Metastasis 16%
• Malignant Neoplasm 16%
• Mucositis 16%
• Paclitaxel 33%
• Plummer-Vinson Syndrome 16%
• Radiation Therapy 33%
• Rare Disease 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Adenoid Cystic Carcinoma 100%
• Carboplatin 33%
• Chemoradiation Therapy 100%
• Dermatitis 16%
• Disease 16%
• Dysphagia 16%
• Lung Metastasis 16%
• Malignant Neoplasm 16%
• Mucosa Inflammation 16%
• Paclitaxel 33%
• Rare Disease 16%